Q3 delivered double-digit sales and profit growth, robust cash flow, and a strengthened balance sheet, driven by successful new releases and a favorable product mix. Outlook remains positive with a strong pipeline and resumed M&A agenda.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.